Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xingyu Mu

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Annals of Nuclear Medicine|March 7, 2025
Insights into lung cancer diagnosis and clinical management using [<sup>18</sup>F]F-fibroblast activation protein inhibitor (FAPI)-42 positron emission tomography/computed tomography (PET/CT)Xingyu Mu, Zhuohao Zhu, Zhenzhen Wang, et al.
BMC Medical Informatics and Decision Making|July 15, 2025
An interpretable machine learning model for predicting bone marrow invasion in patients with lymphoma via <sup>18</sup>F-FDG PET/CT: a multicenter studyXinyu Zhu, Denglu Lu, Yang Wu, et al.
European Radiology|April 27, 2025
Fibroblast activation imaging in rheumatoid arthritis: evaluating disease activity and treatment response using [<sup>18</sup>F]FAPI PET/CTXingyu Mu, Fangyue Zhang, Meng Li, et al.
Frontiers in Endocrinology|December 27, 2021
Efficacy and Safety of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-AnalysisYuan Zhu, Jiao Xu, Dong Zhang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 10, 2022
[<sup>18</sup>F]FAPI-42 PET/CT in differentiated thyroid cancer: diagnostic performance, uptake values, and comparison with 2-[<sup>18</sup>F]FDG PET/CTXingyu Mu, Xiaoxue Huang, Zewen Jiang, et al.
Immunologic Research|July 12, 2020
Hyperprogressive disease in patients with advanced renal cell carcinoma: a new pattern of post-treatment cancer behaviorZhong Zheng, Ke Wu, Zhixian Yao, et al.
BMC Pulmonary Medicine|May 9, 2025
Impact of COPD and sarcopenia on all-cause and respiratory mortality in US adults: NHANES 1999-2018Jiao Xu, Yuehua Ma, Qingyue Zeng, et al.
Clinical and Translational Medicine|February 26, 2021
FTO modifies the m6A level of MALAT and promotes bladder cancer progressionLe Tao, Xingyu Mu, Haige Chen, et al.
Aging|June 20, 2020
Long noncoding RNA LINC00963 induces NOP2 expression by sponging tumor suppressor miR-542-3p to promote metastasis in prostate cancerFeng Sun, Ke Wu, Zhixian Yao, et al.
Journal of Cancer Research and Clinical Oncology|October 8, 2024
Deep learning model using planar whole-body bone scintigraphy for diagnosis of skull base invasion in patients with nasopharyngeal carcinomaXingyu Mu, Zhao Ge, Denglu Lu, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Annals of Nuclear Medicine|March 7, 2025
Insights into lung cancer diagnosis and clinical management using [<sup>18</sup>F]F-fibroblast activation protein inhibitor (FAPI)-42 positron emission tomography/computed tomography (PET/CT)Xingyu Mu, Zhuohao Zhu, Zhenzhen Wang, et al.
BMC Medical Informatics and Decision Making|July 15, 2025
An interpretable machine learning model for predicting bone marrow invasion in patients with lymphoma via <sup>18</sup>F-FDG PET/CT: a multicenter studyXinyu Zhu, Denglu Lu, Yang Wu, et al.
European Radiology|April 27, 2025
Fibroblast activation imaging in rheumatoid arthritis: evaluating disease activity and treatment response using [<sup>18</sup>F]FAPI PET/CTXingyu Mu, Fangyue Zhang, Meng Li, et al.
Frontiers in Endocrinology|December 27, 2021
Efficacy and Safety of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-AnalysisYuan Zhu, Jiao Xu, Dong Zhang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 10, 2022
[<sup>18</sup>F]FAPI-42 PET/CT in differentiated thyroid cancer: diagnostic performance, uptake values, and comparison with 2-[<sup>18</sup>F]FDG PET/CTXingyu Mu, Xiaoxue Huang, Zewen Jiang, et al.
Immunologic Research|July 12, 2020
Hyperprogressive disease in patients with advanced renal cell carcinoma: a new pattern of post-treatment cancer behaviorZhong Zheng, Ke Wu, Zhixian Yao, et al.
BMC Pulmonary Medicine|May 9, 2025
Impact of COPD and sarcopenia on all-cause and respiratory mortality in US adults: NHANES 1999-2018Jiao Xu, Yuehua Ma, Qingyue Zeng, et al.
Clinical and Translational Medicine|February 26, 2021
FTO modifies the m6A level of MALAT and promotes bladder cancer progressionLe Tao, Xingyu Mu, Haige Chen, et al.
Aging|June 20, 2020
Long noncoding RNA LINC00963 induces NOP2 expression by sponging tumor suppressor miR-542-3p to promote metastasis in prostate cancerFeng Sun, Ke Wu, Zhixian Yao, et al.
Journal of Cancer Research and Clinical Oncology|October 8, 2024
Deep learning model using planar whole-body bone scintigraphy for diagnosis of skull base invasion in patients with nasopharyngeal carcinomaXingyu Mu, Zhao Ge, Denglu Lu, et al.
Pageof 6